Electrical Bioimpedance Measurement in Blood Cancer Patients
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a new non-invasive measurement tool (electrical bioimpedance) in patients with AML or MDS who are already having a bone marrow biopsy. The tool sends a mild electrical signal through your body to measure fluid and cell content, which may help doctors better understand and monitor blood cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or confirmed diagnosis of AML (acute myeloid leukemia) or MDS (myelodysplastic syndrome)
- You are 18 years or older
- You are scheduled to have a bone marrow biopsy as part of your medical care
- You can understand and speak English or Spanish
- You do not have electronic implants (like pacemakers, neurostimulators, or electronic prosthetics)
- You are able to provide informed consent and understand the study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain proteins in the blood (called FLT3 ligand and IL6) of people being treated for blood cancers like AML, MDS, or CMML. The goal is to understand how these proteins change during non-intensive chemotherapy, which may help doctors better personalize treatment.
This study follows people who are newly diagnosed (and haven’t been fully treated yet) with specific leukemia or related blood disorders to help researchers learn which treatments may work best. It may help by connecting you to a larger “precision medicine” patient group for future research.
This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.
This study checks whether a detailed blood-cell test can help diagnose myelodysplastic syndrome (MDS), a bone marrow condition that can cause low blood counts. Your results are compared with standard bone marrow testing to see how well the blood test performs.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
This study tests a method called bioimpedance to monitor blood flow in the transplanted belly tissue during breast reconstruction surgery. It may help doctors know when the blood supply is stable, which could lead to safer recovery.
Hear when a new Myelodysplastic Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.